Is contrast enhancement needed for diagnostic prostate MRI?

Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) provides clinical guidelines for multiparametric magnetic resonance imaging (mpMRI) [T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)] of prostate. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Scialpi, Michele, Rondoni, Valeria, Aisa, Maria Cristina, Martorana, Eugenio, D’Andrea, Alfredo, Malaspina, Corrado Maria, Orlandi, Agostino, Galassi, Giorgio, Orlandi, Emanuele, Scialpi, Pietro, Dragone, Michele, Palladino, Diego, Simeone, Annalisa, Amenta, Michele, Bianchi, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503975/
https://www.ncbi.nlm.nih.gov/pubmed/28725592
http://dx.doi.org/10.21037/tau.2017.05.31
Descripción
Sumario:Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) provides clinical guidelines for multiparametric magnetic resonance imaging (mpMRI) [T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)] of prostate. However, DCE-MRI seems to show a limited contribution in prostate cancer (PCa) detection and management. In our experience, DCE-MRI, did not show significant change in diagnostic performance in addition to DWI and T2WI [biparametric MRI (bpMRI)] which represent the predominant sequences to detect suspected lesions in peripheral and transitional zone (TZ). In this article we reviewed the role of DCE-MRI also indicating the potential contribute of bpMRI approach (T2WI and DWI) and lesion volume evaluation in the diagnosis and management of suspected PCa.

Ejemplares similares